Fresenius Medical Care AG FME.DE
Fresenius Medical Care AG statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (€61.21); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Fresenius Medical Care AG trades at about 12.2× earnings — below its 10-year norm (10-year range 11.3×–26.3×, median 21.2×).
Shaded band = 10-year range (11.3×–26.3×); dot = today's 12.2×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 25.6% | 24.6% | 25.3% | 25.2% |
| Operating margin | 9.3% | 7.6% | 7.6% | 7.5% |
| Net margin | 5.0% | 2.8% | 2.6% | 3.5% |
| FCF margin | 9.0% | 8.7% | 10.0% | 7.4% |
| Return on assets | 3.2% | 1.6% | 1.5% | 1.9% |
| Return on equity | 7.4% | 3.7% | 3.7% | 4.8% |
| Debt / equity | 0.43× | 0.43× | 0.51× | 0.51× |
| Current ratio | 1.26 | 1.40 | 1.42 | 1.27 |
Computed from company filings · DE · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.